Here is the synopsis of our sample research paper on Genetic Testing for Congenital Anomalies. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
This 5 page paper discusses several different aspects of genetic testing, including who are candidates for screening, discrimination, costs, privacy issues, clinical issues for mutation carriers and ethical and social considerations. Bibliography lists 10 sources.
Page Count:
5 pages (~225 words per page)
File: D0_HVGenTst.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
the first place. This paper discusses some of the issues surrounding genetic testing for congenital anomalies. Discussion There are several kinds of DNA testing: "testing for a specific disorder, presymptomatic
testing, predictive testing, and predisposition testing" (Hall, 2000). While DNA testing is anticipated to be relatively inexpensive, "the availability of DNA testing is changing the way referrals occur and the
patenting of the human genome may lead to restricted access, increased costs, and concerns about quality assurance" (Hall, 2000). Candidates for Screening: There doesnt appear to be any hard and
fast rule about who should or should not undergo genetic testing. The examples most usually mentioned are young women who have female relatives who have, or have had, breast cancer.
In fact, the question has arisen: "To whom should DNA-based genetic testing be offered?" (Pinsky et al, 2001, p. 168). The fact that the question is phrased as "offered" rather
than "recommended" indicates there are two dynamic parts to the decision of whether or not to test (Pinsky et al, 2001). First, "is there a medical indication for the testing?
and second, how do the benefits and risks of testing coincide with the patients reasons for testing and management decisions she would make based on the results?" (Pinsky, et al,
2001, p. 168). In the case of breast cancer, once a mutation that can cause cancer has been discovered, testing is easy and can be done with a simple
blood test (Pinsky et al, 2001). But there are several other factors that indicate how difficult this situation can become. First, the reason why some people are predisposed to cancer
in high-risk families while others are not has not been clearly identified; this can lead to false-negatives that could delay treatment (Pinsky et al, 2001). Second, testing can give
...